Abstract
To investigate whether cancer is associated with Alzheimer disease (AD) and vascular dementia (VaD). Cox proportional hazards models were used to test associations between prevalent dementia and risk of future cancer hospitalization, and associations between prevalent cancer and risk of subsequent dementia. Participants in the Cardiovascular Health Study-Cognition Substudy, a prospective cohort study, aged 65 years or older (n = 3,020) were followed a mean of 5.4 years for dementia and 8.3 years for cancer. The presence of any AD (pure AD + mixed AD/VaD; hazard ratio [HR] = 0.41, 95% confidence interval [CI] = 0.20-0.84) and pure AD (HR = 0.31, 95% CI = 0.12-0.86) was associated with a reduced risk of future cancer hospitalization, adjusted for demographic factors, smoking, obesity, and physical activity. No significant associations were found between dementia at baseline and rate of cancer hospitalizations for participants with diagnoses of VaD. Prevalent cancer was associated with reduced risk of any AD (HR = 0.72; 95% CI = 0.52-0.997) and pure AD (HR = 0.57; 95% CI = 0.36-0.90) among white subjects after adjustment for demographics, number of APOE epsilon4 alleles, hypertension, diabetes, and coronary heart disease; the opposite association was found among minorities, but the sample size was too small to provide stable estimates. No significant association was found between cancer and subsequent development of VaD. In white older adults, prevalent Alzheimer disease (AD) was longitudinally associated with a reduced risk of cancer, and a history of cancer was associated with a reduced risk of AD. Together with other work showing associations between cancer and Parkinson disease, these findings suggest the possibility that cancer is linked to neurodegeneration.
MeSH Terms
Aged
Aged, 80 and over
Alzheimer Disease/epidemiology,genetics
Cohort Studies
Dementia, Vascular/epidemiology,genetics
Female
Genetic Predisposition to Disease/genetics
Hospitalization/statistics & numerical data,trends
Humans
Male
Neoplasms/epidemiology,genetics
Nerve Degeneration/epidemiology,genetics
Parkinson Disease/epidemiology,genetics
Prevalence
Proportional Hazards Models
Prospective Studies
Risk Assessment/methods
Risk Factors
Whites
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Roe C M
Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA. cathyr@wustl.edu
Fitzpatrick A L
Xiong C
Sieh W
Kuller L
Miller J P
Williams M M
Kopan R
Behrens M I
Morris J C
References (23)
23 references, click to expand
-
Evaluation of dementia in the cardiovascular health cognition study.
Neuroepidemiology. 2003 Jan-Feb;22(1):1-12
PMID: 12566948
-
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Cancer. 1997 Oct 15;80(8):1438-47
PMID: 9338468
-
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study.
Ann Epidemiol. 1995 Jul;5(4):278-85
PMID: 8520709
-
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.
Nat Rev Mol Cell Biol. 2007 Nov;8(11):904-16
PMID: 17878917
-
Alzheimer disease and cancer.
Neurology. 2005 Mar 8;64(5):895-8
PMID: 15753432
-
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
Neurochem Res. 2007 Apr-May;32(4-5):577-95
PMID: 16944320
-
Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities.
J Neurosci. 2007 Oct 3;27(40):10849-59
PMID: 17913918
-
Are Parkinson disease patients protected from some but not all cancers?
Neurology. 2007 Oct 9;69(15):1542-50
PMID: 17699801
-
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
Neurology. 1984 Jul;34(7):939-44
PMID: 6610841
-
A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease.
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1260-5
PMID: 17548694
-
Cancer statistics, 2007.
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
PMID: 17237035
-
The Cardiovascular Health Study: design and rationale.
Ann Epidemiol. 1991 Feb;1(3):263-76
PMID: 1669507
-
Tumours and tremors: how PTEN regulation underlies both.
Br J Cancer. 2006 Mar 13;94(5):620-4
PMID: 16495927
-
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
Neurology. 2005 May 10;64(9):1539-47
PMID: 15883314
-
Epidemiology and pathophysiology of prostate cancer in African-American men.
J Urol. 2007 Feb;177(2):444-9
PMID: 17222606
-
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.
Neurology. 1992 Mar;42(3 Pt 1):473-80
PMID: 1549205
-
Survival following dementia onset: Alzheimer's disease and vascular dementia.
J Neurol Sci. 2005 Mar 15;229-230:43-9
PMID: 15760618
-
Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.
J Am Geriatr Soc. 2005 Jul;53(7):1101-7
PMID: 16108925
-
Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).
Cancer Causes Control. 2006 Mar;17(2):187-97
PMID: 16425097
-
Determinants of vascular dementia in the Cardiovascular Health Cognition Study.
Neurology. 2005 May 10;64(9):1548-52
PMID: 15883315
-
Current concepts in mild cognitive impairment.
Arch Neurol. 2001 Dec;58(12):1985-92
PMID: 11735772
-
Incidence and prevalence of dementia in the Cardiovascular Health Study.
J Am Geriatr Soc. 2004 Feb;52(2):195-204
PMID: 14728627
-
The Modified Mini-Mental State (3MS) examination.
J Clin Psychiatry. 1987 Aug;48(8):314-8
PMID: 3611032